期刊文献+

帕金森老年患者的认知功能损伤状况研究 被引量:2

Investigation on cognitive impairment of elder Parkinson patients
原文传递
导出
摘要 目的探讨老年帕金森病患者认知功能损伤状况,分析老年帕金森患者认知功能损伤的特点。方法将2013年7月至2014年12月间就诊于我院的193例老年帕金森病患者分为帕金森伴发认知功能损伤(PD-CI)组和帕金森病认知功能正常(PD-NCI)组,应用蒙特利尔认知评估量表(Mo CA)、帕金森病生活质量问卷(PDQ-39)及汉密尔顿抑郁量表(HAMD)等对患者的非运动症状进行诊断和评估。结果 PD-CI组7项Mo CA评分均显著低于PD-NCI组(P<0.05)。PD-NCI组病程[(3.15±2.98)年]显著性短于PD-CI组[(4.52±3.41)年](P<0.05),而受教育程度PD-NCI组显著高于PD-CI组(P<0.05)。PD-CI组生存质量得分(132.73±12.41)显著低于PD-NCI组(144.53±11.89)(P<0.05)。生活自理能力PD-NCI组(47.14±4.22)优于PD-CI组(38.67±3.62)(P<0.05)。PD-CI组抑郁率为82.65%,PD-NCI组为54.74%;PD-CI组抑郁等级显著高于PD-NCI组(U=19.430,P<0.05)。结论认知功能障碍对患者生活影响大,应对其充分研究并制定相应的医疗措施有利于提高患者生存质量。 Objective To investigate the cognitive impairment (CI) of elder Parkinson patients and analyze the features of elder Parkinson patients with CI. Methods From July 2013 to December 2014 in our hospital, 193 cases of PD patients were selected and randomly divided into PD with cognitive impairment (PD-CI) group and PD with no cognitive impairment (PD-NCI) group. Diagnosed and evaluated the non motor symptoms (NMS) by The Montreal Cognitive Assessment (MoCA), PD Quality-39 (PDQ-39) and Hamilton Depression Scale (HAMD). Results The MoCA scores of PD-CI group were significantly lower than that of PD-NCI group (P<0.05). The PD-NCI group (3.15±2.98) years was short than PD-CI (4.52±3.41) years in course of disease (P<0.05), and the education level of PD-NCI was significantly higher than PD-CI (P<0.05). The life quality of PD-CI (132.73±12.41) was significantly lower than PD-NCI (144.53±11.89) (P<0.05). Ability of daily living, PD-NCI (47.14±4.22) was better than PD-CI (38.67±3.62) (P<0.05). Depression rate of PD-CI group was 82.65% and 54.74% for PD-NCI. The depression rate of PD-CI was significantly higher than PD-NCI (U=19.430, P<0.05). Conclusion Cognitive impairment is great obstacle of normal life for PDs, it’s valuable for improving the life quality of PDs to study CI and make corresponding therapy.
出处 《中华临床医师杂志(电子版)》 CAS 2015年第22期16-19,共4页 Chinese Journal of Clinicians(Electronic Edition)
基金 国家自然科学基金(30870869)
关键词 帕金森病 认知功能损伤 老年患者 Parkinson disease Cognitive impairment Elder patients
  • 相关文献

参考文献18

  • 1刘骏, 曹园. 帕金森病相关LRRK2 的遗传特征分析[J/CD]. 中华临床医师杂志:电子版, 2013, 7(24): 11821-11825.
  • 2Khedr EM. Prevalence of non motor features in a cohort ofParkinson's disease patients[J]. Clin Neurol Neurosurg, 2013, 115(6):673-677.
  • 3蒋雨平,王坚,丁正同,邬剑军,陈嬿.原发性帕金森病的诊断标准(2005年)[J].中国临床神经科学,2006,14(1):40-40. 被引量:155
  • 4张熙悫,娄凡,刘娜,罗晓光,任艳.帕金森病伴发抑郁的研究进展[J].中华临床医师杂志(电子版),2015,9(4):108-111. 被引量:11
  • 5Zesiewicz TA, Sullivan KL, Hauser RA. Levodopa-induceddyskinesia in Parkinson's disease: epidemiology, etiology, andtreatment[J]. Curr Neurol Neurosci Rep, 2007, 7(4): 302-310.
  • 6Gallagher DA, Goetz CG, Stebbins G, et al. Validation of theMDS-UPDRS Part I for nonmotor symptoms in Parkinson'sdisease[J]. Mov Disord, 2012, 27(1): 79-83.
  • 7Garcia-Ruiz PJ, Chaudhuri KR, Martinez-Martin P. Non-motorsymptoms of Parkinson's disease A review from the past[J]. J NeurolSci, 2014, 338(1/2): 30-33.
  • 8Lin CH, Wu RM. Biomarkers of cognitive decline in Parkinson'sdisease[J]. Parkinsonism Relat Disord, 2015, 21(5) : 431-443.
  • 9Chaudhuri KR, Healy DG, Schapira AH. Non-motor symptoms ofParkinson's disease: diagnosis and management[J]. Lancet Neurology,2006, 5(3): 235-245.
  • 10Huang YC. Prevalence and risk factors of cognitive impairment inParkinson disease: a population-based case-control study in taiwan[J].Medicine (Baltimore), 2015, 94(17): 782.

二级参考文献82

  • 1张朝佑.人体解剖学[M].第3版.北京:人民卫生出版,2009:1914.
  • 2Braak H, Del Tredici K, Rub U, et al. Staging of brain pathology related to sporadic Parkinson' s disease [ J l. Neurobiol Aging, 2003, 24 (2) : 197-211.
  • 3Zarow C, Lyness SA, Mortimer JA, et al. Neuronal loss is greater in the locus coeruleus than nucleus basalis and substantia nigra in Alzheimer and Parkinson diseases [ J ]. Arch Neurol, 2003, 60 (3) :337-341.
  • 4Dickson DW. Parkinson ' s disease and parkinsonism : neuropathology [ J]. Cold Spring Harb Perspect Med, 2012, 2 (8) : a009258.
  • 5Del Tredici K, Rub U, De Vos RA, et al. Where does parkinson disease pathology begin in the brain [ J ] ? J Neuropathol Exp Neurol, 2002, 61 ( 5 ) :413-426.
  • 6Marien MR, Colpaert FC, Rosenquist AC. Noradrenergic mechanisms in neurodegenerative diseases: a theory [ J]. Brain Res Brain Res Rev, 2004, 45(1 ):38-78.
  • 7German DC, Manaye KF, White CL 3rd, et al. Disease-specific patterns of locus eoeruleus cell loss [ J]. Ann Neural, 1992, 32 (5) :667-676.
  • 8Patt S, Gerhard L. A Golgi study of human locus coeruleus in normal brains and in Parkinson' s disease [ J ]. Neuropathol Appl Neurobiol, 1993, 19(6) :519-523.
  • 9Gesi M, Soldani P, Giorgi FS, et al. The role of the locus eoeruleus in the development of Parkinson' s disease [ J]. Neurosei Biobehav Rev, 2000, 24(6):655-668.
  • 10Baloyannis SJ, Costa V, Baloyannis IS. Morphological alterations of the synapses in the locus eoeruleus in Parkinson' s disease [ J]. J Neural Sci, 2006, 248(1-2) :35-41.

共引文献185

同被引文献17

引证文献2

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部